Tim Sandle (Bio Products Laboratory and University of Manchester)

article

Innovation in real-time next-generation sequencing provides pharmaceutical benefits

11 January 2021 | By Tim Sandle (Bio Products Laboratory and University of Manchester)

Tim Sandle explains how next-generation sequencing (NGS) could aid in the development of novel antimicrobials to overcome multi-drug resistance.

article

Release of sterile medicinal products – looking at the focal points

25 August 2020 | By Tim Sandle (Bio Products Laboratory and University of Manchester)

There are numerous risks and regulatory requirements that must be considered to ensure appropriate contamination control of sterile medicinal products. Tim Sandle discusses the complexities of sterility assurance and provides guidance for manufacturers to ensure that appropriate risk management processes are in place.